Author

Xiaoping Li

Observed name: Li, Xiaoping

Institution: Jiangmen Central Hospital

Observed institutions: Army Medical University, Jiaxing University, Xinqiao Hospital, Zhejiang Shuren University, Jiangmen Central Hospital, Chinese People's Liberation Army, Union Hospital

ORCID: 0000-0002-9215-9611

Observed ORCID: 0000-0002-9215-9611

OpenAlex ID: A5079733174

PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives

2024 · Zhaoyang Zhu, Yigang Jin, et al. · Molecular Cancer · 95

Developing role of B cells in the pathogenesis and treatment of chronic GVHD

2018 · Xiaoping Li, Qiangguo Gao, et al. · British Journal of Haematology · 47

Matrix metalloproteinases targeting in prostate cancer

2024 · Shuying Zhu, Jing He, et al. · Urologic Oncology Seminars and Original Investigations · 26

Anbenitamab plus albumin-bound docetaxel (nab-docetaxel) ± carboplatin (Cb) versus trastuzumab and pertuzumab plus docetaxel (THP) ± Cb as neoadjuvant therapy for HER2-positive early or locally advanced breast cancer: A randomized, open-label, multicenter, phase 3 trial.

2026 · Zhi-Ming Shao, Peng Ji, et al. · Journal of Clinical Oncology · 4

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study

2024 · Jieling Jiang, Xiaofan Li, et al. · eJHaem · 4

Genomic and transcriptomic profiling of inflammatory breast cancer reveals distinct molecular characteristics to non-inflammatory breast cancers

2024 · Kaiwen Zhou, Mengmeng Zhang, et al. · Breast Cancer Research and Treatment · 3

Stable engraftment, as well as graft versus host disease‐free and relapse‐free survival brought by the combination of CD7 targeted universal chimeric antigen receptor‐T, and donor hemopoietic stem cells: Indication of a case report

2024 · Shiqi Li, Zhongtao Yuan, et al. · eJHaem · 2

Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer

2026 · Jiayu Wang, Huiping Li, et al. · New England Journal of Medicine · 1

The Combination of Intravenous Immunoglobulin, Dexamethasone, and a High Dose of Mononuclear Cells Transfusion: An Effective Strategy for Decreasing Donor-Specific Antibodies During Haploidentical Hematopoietic Stem Cell Transplantation

2025 · Xiaoping Li, Yu Li, et al. · Cell Transplantation · 1

Advances in diagnostic assays for Clostridioides difficile infection in adults

2024 · Dong-ang Liu, Shiyu Chen, et al. · Frontiers in Cellular and Infection Microbiology · 1

Izalontamab brengitecan for HR+/HER2– breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial

2026 · Bo Lan, Yehui Shi, et al. · The Lancet

Works count: 14

Citation count: 184

H-index: 4

I10-index: 3